Five things to know:
1. Geisinger’s outlook is stable, and it has about $1.3 billion of debt outstanding, according to Moody’s.
2. The downgrade reflects expectations that Geisinger’s will lead to weak operating cash flow for a protracted period.
3. The “A2” rating reflects expectations that Geisinger will continue to benefit from its clinical footprint of tertiary and quaternary services and leading market capture across central and northeastern Pennsylvania. Moody’s said this will be supported by strong brand recognition and system growth initiatives.
4. Factors that could lead to a rating upgrade include stronger and sustained operating cash flow margins and strengthening of balance sheet metrics.
5. Failure to improve operating performance to targeted levels could result in further rating downgrades.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.